Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HW-N2001 Injection vs Esomeprazole for Peptic Ulcer Bleeding (Phase II, China)
CTR20242741Phase 2Completed
- Sponsor
- Shandong Daohe Pharmaceutical
- Start
- Jul 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of hemocoagulase agkistrodon in upper gastrointestinal bleeding (UGIB), Peptic ulcer disease (PUD), gastric ulcer, duodenal ulcer, sponsored by Shandong Daohe Pharmaceutical. Started Jul 2024; status: completed.
02
Drugs
hemocoagulase agkistrodon
03
Conditions
upper gastrointestinal bleeding (UGIB)Peptic ulcer disease (PUD)gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on CTR20242741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242741.